Maridea Wealth Management’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History
Bought
Maintained
Sold
Other funds holding BTAL
FDCDDQ
OIA
WIA
CCMG
Maridea Wealth Management's BTAL Position: Q3 2025 in Review
Maridea Wealth Management sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q3 2025, closing a stake of 34,887 shares — an estimated $618K sold.
Maridea Wealth Management first reported a position in BTAL in Q4 2024 and held it in 3 quarters. The position peaked at $4.62M in Q1 2025. 71 funds tracked by Wall St. Rank hold BTAL as of Q3 2025.
- Maridea Wealth Management reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q3 2025 after selling out during the quarter.
- Maridea Wealth Management sold 34,887 AGF US Market Neutral Anti-Beta Fund shares in Q3 2025, an estimated $618K.
- Maridea Wealth Management first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2024 and held it in 3 quarters.
- Maridea Wealth Management's AGF US Market Neutral Anti-Beta Fund position peaked at $4.62M in Q1 2025.
- 71 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q3 2025.
Based on Maridea Wealth Management's 13F filing for Q3 2025, filed 7 Nov 2025.